Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT7519M in Relapsed/Refractory CLL
NCT01627054Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Aug 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AT-7519 in chronic lymphocytic leukemia (CLL), sponsored by Canadian Cancer Trials Group. Started Aug 2012; status: completed.
02
Drugs
AT-7519
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01627054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627054.